On 22 March, Prof. Hendrik Van Poppel and Prof. John Brandt Brodersen discussed Prostate Cancer Screening under the moderation of Prof. Ferdinando Petrazzuoli. Prostate cancer is the second most common cancer in men worldwide. Although PSA remains the most used test for screening, the limited specificity and an elevated rate of over diagnosis are a problem. Recently a number of novel biomarkers aiming to increase ability to select patients for biopsy and identify men at risk seem to be promising. This debate added some new perspective on the topic giving the audience the understanding of whether to screen, how often and with what.
The recording is available on the Wonca Europe YouTube page: